No Data
Insider Sale: Chief Scientific Officer Stephen Betz Sells 3,000 Shares of Crinetics ...
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)
Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Pipeline and Regulatory Progress
Express News | Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
We Think Crinetics Pharmaceuticals (NASDAQ:CRNX) Can Afford To Drive Business Growth
Investors Might Be Losing Patience for Crinetics Pharmaceuticals' (NASDAQ:CRNX) Increasing Losses, as Stock Sheds 4.3% Over the Past Week